Log in to save to my catalogue

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89e9d0c72e4748d8b799e34e9e77cedb

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence

About this item

Full title

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2020-01, Vol.12 (1), p.44

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Medication adherence is a growing concern for public health and poor adherence to therapy has been associated with poor health outcomes and higher costs for patients. Interventions for improving adherence need to consider the characteristics of the individual therapeutic regimens according to the needs of the patients. In particular, geriatric and...

Alternative Titles

Full title

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_89e9d0c72e4748d8b799e34e9e77cedb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_89e9d0c72e4748d8b799e34e9e77cedb

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics12010044

How to access this item